website

ArtemiC

PHASE II CONTROLLED CLINICAL STUDY

CLINICALLY VALIDATED

ArtemiC™ has been tested for safety and efficacy in a double-blind, placebo-controlled clinical trial of 50 patients diagnosed with COVID-19.

In the phase II clinical study, ArtemiC™ statistically improved the recovery of patients infected with COVID-19.

All patients had confirmed COVID-19 infection, were in stable, moderate condition in the hospital, and were between the ages of 40 and 75 years old.

Gift for Mom
ArtemiC Support 30ml

CHF 73.71 CHF 81.90

    Gift for Mom
    ArtemiC Rescue 5ml

    CHF 73.71 CHF 81.90

      Sale

      Unavailable

      Sold Out